Because it's virtually de-risked. Prior to that there was no real certainty of approval realistically. It was still largely a binary events and we know how binary events go in this space. The market sold off prior to approval in case of the rejection, which happened.
Given that it's just the packaging, you'd think this would now be a non-issue going forward.
The product is clearly a stand out amongst what is out there. The management team is world class. Vinnie sold Anacor to pfizer for $5.2 billion. He's head and shoulders above the rest of the bio management teams on the ASX.
You also need to look at the comparative market caps of CU6 and MSB.
Botanix is severely lagging these and has a product a lot further in the piece.
The market is not pricing a lot of upside in here. We will re-rate heavily again shortly.
All in my humble opinion of course.
- Forums
- ASX - By Stock
- Bot Chart
Because it's virtually de-risked. Prior to that there was no...
-
- There are more pages in this discussion • 2,322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $760.2M |
Open | High | Low | Value | Volume |
40.0¢ | 42.0¢ | 40.0¢ | $3.466M | 8.500M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 82195 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 301931 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 82195 | 0.410 |
5 | 369723 | 0.405 |
19 | 474112 | 0.400 |
9 | 563648 | 0.395 |
4 | 326851 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 301931 | 9 |
0.425 | 181292 | 6 |
0.430 | 368611 | 17 |
0.435 | 51271 | 4 |
0.440 | 228227 | 8 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |